Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446589
Status:
TERMINATED
Last Update Posted:
2014-10-29
First Post:
2007-03-12
Brief Title:
The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density
Sponsor:
Papageorgiou General Hospital
Organization:
Papageorgiou General Hospital
Study Overview
Official Title:
None
Status:
TERMINATED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
due to financial problems
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hemodialysis patients with low bone density total hip T-score -25 will be assigned to receive teriparatide those with histologic confirmation of adynamic bone disease or ibandronate subjects with increased osteoclast number on bone biopsy
Follow-up period one year A second bone biopsy at the end of the study
Follow-up period one year A second bone biopsy at the end of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None